Business Description
Zynex Inc
NAICS : 423460
SIC : 5122
ISIN : US98986M1036
Description
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.59 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.65 | |||||
| Debt-to-EBITDA | 4.26 | |||||
| Interest Coverage | 9.85 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.93 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.8 | |||||
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year EPS without NRI Growth Rate | -4.7 | |||||
| 3-Year Book Growth Rate | -1.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 23.45 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.56 | |||||
| 9-Day RSI | 28.21 | |||||
| 14-Day RSI | 33.2 | |||||
| 6-1 Month Momentum % | 75.05 | |||||
| 12-1 Month Momentum % | 8.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.74 | |||||
| Quick Ratio | 4.03 | |||||
| Cash Ratio | 2.41 | |||||
| Days Inventory | 131.83 | |||||
| Days Sales Outstanding | 63.45 | |||||
| Days Payable | 64.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 4.9 | |||||
| Shareholder Yield % | 1.66 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.19 | |||||
| Operating Margin % | 5.85 | |||||
| Net Margin % | 5.28 | |||||
| FCF Margin % | 8.98 | |||||
| ROE % | 16.34 | |||||
| ROA % | 7.28 | |||||
| ROIC % | 10.28 | |||||
| ROC (Joel Greenblatt) % | 28 | |||||
| ROCE % | 11.91 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.08 | |||||
| Forward PE Ratio | 21.89 | |||||
| PE Ratio without NRI | 48.41 | |||||
| Shiller PE Ratio | 54.7 | |||||
| Price-to-Owner-Earnings | 21.93 | |||||
| PEG Ratio | 2.92 | |||||
| PS Ratio | 2.15 | |||||
| PB Ratio | 7.81 | |||||
| Price-to-Tangible-Book | 20.64 | |||||
| Price-to-Free-Cash-Flow | 23.46 | |||||
| Price-to-Operating-Cash-Flow | 21.88 | |||||
| EV-to-EBIT | 28.53 | |||||
| EV-to-EBITDA | 21.81 | |||||
| EV-to-Revenue | 2.12 | |||||
| EV-to-Forward-Revenue | 1.72 | |||||
| EV-to-FCF | 23.57 | |||||
| Price-to-Projected-FCF | 2.25 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.09 | |||||
| Price-to-Graham-Number | 6.63 | |||||
| Earnings Yield (Greenblatt) % | 3.51 | |||||
| FCF Yield % | 4.74 | |||||
| Forward Rate of Return (Yacktman) % | 22.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ZYXI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zynex Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 184.322 | ||
| EPS (TTM) ($) | 0.26 | ||
| Beta | 0.59 | ||
| Volatility % | 42.5 | ||
| 14-Day RSI | 33.2 | ||
| 14-Day ATR ($) | 0.366808 | ||
| 20-Day SMA ($) | 12.011 | ||
| 12-1 Month Momentum % | 8.4 | ||
| 52-Week Range ($) | 6.88 - 14.75 | ||
| Shares Outstanding (Mil) | 31.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zynex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zynex Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zynex Inc Frequently Asked Questions
What is Zynex Inc(ZYXI)'s stock price today?
The current price of ZYXI is $10.94. The 52 week high of ZYXI is $14.75 and 52 week low is $6.88.
When is next earnings date of Zynex Inc(ZYXI)?
The next earnings date of Zynex Inc(ZYXI) is 2024-04-30.
Does Zynex Inc(ZYXI) pay dividends? If so, how much?
Zynex Inc(ZYXI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers